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Abstract Constitutive activation of Notch signaling is known to
be associated with tumorigenesis. In a mouse T lymphoma cell
line, DL-3, we found that a murine leukemia provirus was
inserted in the Notch1 locus, which led to marked expression of a
virus-Notch1 fusion mRNA encoding an intracellular portion of
the Notch1 protein. Furthermore, expression and nuclear
localization of this constitutively active form of Notch1 protein
were confirmed. Corresponding to this finding, the transcription
of the hairy/enhancer of split (HES-1) gene, a known target of
Notch1 signaling, was elevated in this cell line. A potential role
for overexpressed HES-1 in the development of the lymphoma
was discussed.
z 1999 Federation of European Biochemical Societies.
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1. Introduction
Notch family genes encode transmembrane receptor pro-
teins mediating signals which regulate various cell fate deci-
sions that involve cell-cell interactions [1]. The Notch proteins
are characterized by an extracellular domain containing EGF-
like repeats which bind the Delta-Serrate-Lag2 family of lig-
and proteins, and Notch/lin-12 repeats of unknown function,
and by an intracellular domain containing a RAM domain
and Cdc10/ankyrin repeats, both of which can bind the
RBP-J/CBF-1 transcription factor [1^3]. Recent reports
showed that the binding of Notch ligand induces proteolytic
cleavage of Notch [4^10]. The cleaved intracellular form of
Notch makes a complex with RBP-J/CBF-1, translocates
into the nucleus and regulates transcription of target genes,
such as the hairy/enhancer of split (HES) gene encoding a
basic helix-loop-helix transcription factor [10^13].
Loss of the extracellular domain of the Notch protein
causes constitutive activation of the protein, known to be
associated with induction of lymphomas [14^17] and mam-
mary tumors [18]. In human T cell acute lymphoblastic leu-
kemia, the chromosomal translocation t(7;9) joins a portion
of Notch1/Tan1 to the T cell receptor L locus [14]. The Notch1
gene is also known to be a target of provirus insertions in T
cell lymphomas arising in Moloney murine leukemia virus
(Mo-MuLV)-infected MMTVD/myc transgenic mice suggest-
ing that c-myc and Notch1 collaborate for oncogenesis [15].
Furthermore, Robey et al. have demonstrated that the over-
expression of the activated form of mouse Notch1 biases T
cell development toward CD8 single-positive T cells, indicat-
ing that Notch1 is involved in T cell fate determination [19].
However, the target(s) of Notch1 signaling in the processes of
T cell development and transformation remains elusive.
Here, we describe a mouse T lymphoma cell line, DL-3,
with a MuLV provirus insertion in one of the Notch1 alleles,
which led to ectopic expression of a truncated Notch1 mRNA
and protein. The transcription ofHES-1, a member of the
HES family, was markedly elevated in this cell line, suggesting
that the leukemogenic function of the truncated Notch1 pro-
tein was mediated by activation of HES-1.
2. Materials and methods
2.1. Cell culture
The three T lymphoma cell lines DL-3, 333A, and DL-5 were es-
tablished from lymphomas spontaneously developed in DBA/2 mice
in our laboratory [20] and were cultured in RPMI 1640 medium
supplemented with 10% fetal calf serum.
2.2.. Southern and Northern blot analyses
Twenty micrograms of genomic DNA extracted from lymphoma
cell lines was digested with restriction endonucleases, and Southern
blotted as described [21]. For Northern blot analyses, 10 Wg of total
RNA was prepared and analyzed as described [21].
The following DNA fragments were isolated from the pBluescript II
KS containing the Notch1 cDNA and used as probes for Southern
and Northern analyses: middle probe, a 0.7-kb BamHI-SacI fragment
encoding the region from the C-terminus of the EGF-like repeats to
the N-terminus of the transmembrane domain. Extracellular probe: a
2.8-kb ClaI fragment encoding the region from the N-terminus to
EGF-like repeats. Intracellular probe: a 1.9-kb NotI fragment encod-
ing the region from the Cdc10/ankyrin repeats to the C-terminus of
Notch1. A 1.3-kb EcoRI fragment from pSV2-CMV HES-1, the plas-
mid containing rat HES-1 cDNA (a gift from Dr. R. Kageyama,
Kyoto University) was used as a probe for Northern analysis. A
3.5-kb BamHI fragment from pPAN7, the plasmid containing human
elongation factor-1K cDNA (a gift from Dr. S. Nagata, Osaka Uni-
versity) was used as a probe for RNA loading control. For quantita-
tive analysis of Northern blotting, the X-ray ¢lms were scanned with a
densitometer (Shimadzu, Japan).
2.3. Screening and sequencing of Notch1 cDNA
The cDNA library of DL-3 was prepared from poly-(A) RNAs
selected with the Poly(A) Quick mRNA Isolation Kit (Stratagene), by
using the ZAP Express cDNA Synthesis Kit and ZAP Express Giga-
packII Gold Cloning Kit (Stratagene). To obtain clones with the
Notch1 sequences, the cDNA library was screened with a 32P-labeled
Notch1 intracellular probe. The clones hybridized with intracellular
probe were rescued as pBK-CMV plasmids by in vivo excisions and
the cDNA inserts in these plasmids were sequenced. Thermo Sequen-
ase (Amersham) Kit and 373 SEQUENCER (Applied Biosystems)
were used for nucleotide sequence analysis. Sequence homology be-
tween the cDNA insert and the MuLV LTR ([22], GenBank accession
number M13079) or the Notch1 cDNA ([2], GenBank accession num-
ber Z11886) was analyzed. In this report, all nucleotide positions of
the Notch1 cDNA and MuLV are cited from these databases. The
nucleotide sequences of the regions of interest of the clone dl-3B
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(see Fig. 2A) have been entered in EMBL Nucleotide Sequence Data-
base with the accession number AJ238029.
2.4. Immunoblot analysis
The cell lysates were subjected to SDS-polyacrylamide gel electro-
phoresis, and Western blotted as described [23]. The blot was incu-
bated with rabbit antibody against the RAM23 domain of the Notch1
protein, followed by the peroxidase-conjugated secondary antibody
against rabbit IgG (Bio-Rad). The blots were visualized with the En-
hanced Chemiluminescence Reagent (Amersham).
2.5. Immunostaining
DL-3 cells were ¢xed, permeabilized, and blocked as described [23].
The samples were processed for indirect immunostaining with the
rabbit antiserum against-Cdc10/ankyrin repeats of Notch1 (1:1000
dilution), or the pre-immune rabbit serum (1:1000 dilution) followed
by £uorescein isothiocyanate (FITC)-conjugated goat anti-rabbit im-
munoglobulins (Cappel). The samples were observed using Radiance
Plus confocal laser microscope (Bio-Rad).
3. Results
3.1. Rearrangement of the Notch1 gene in a DBA/2 mouse T
lymphoma cell line
Fifteen T cell lines established from spontaneously devel-
oped lymphomas of DBA/2 mice were screened for rearrange-
ment of Notch genes by Southern blotting. Although no re-
arrangement of Notch2, 3 or 4 was detected (data not shown),
rearrangement of the Notch1 gene was found in a cell line
named DL-3 (Fig. 1). In addition to the 2-kb PstI and the
4.2-kb BamHI fragments derived from the una¡ected Notch1
allele, the Notch1 middle probe hybridized with an additional
1.2-kb PstI and an additional 2.7-kb BamHI fragment in the
DL-3 genomic DNA. To further characterize this Notch1 gene
rearrangement, we constructed restriction maps of the unaf-
fected Notch1 allele (in normal liver cells) and the rearranged
Notch1 allele in DL-3 (data not shown). A comparison of
these two maps indicated that DL-3 has a rearrangement in
one allele of the Notch1 gene: an insert of 9 kb in the region
between the Notch/lin-12 repeats and the transmembrane do-
main encoding sequences.
3.2. Overexpression of truncated Notch1 transcripts in DL-3
Next, we analyzed whether the rearrangement of the Notch1
genome a¡ects the expression of Notch1 transcripts in DL-3.
Marked expression of a 3-kb and a 5-kb transcript was de-
tected with the intracellular (Fig. 2, middle panel) and the
extracellular (Fig. 2, left panel) probes, respectively, in DL-
3. However, none of these unusual Notch1 RNA species was
detected in 333A and DL-5 cell lines, which have normal
Notch1 alleles. Therefore, rearrangement of the Notch1 locus
in DL-3 induced the expression of the 3-kb and the 5-kb RNA
species, which only encode the intracellular and the extracel-
lular domain of Notch1, respectively. Expression of the nor-
mal Notch1 RNA species of 8 kb was undetectable in all of
these cell lines (Fig. 2, left panel).
3.3. Structure of the truncated Notch1 transcript
To further characterize the mechanism of Notch1 rearrange-
ment and to de¢ne the structure of the truncated Notch1 tran-
scripts, a cDNA library of the DL-3 cell line was screened
with the intracellular Notch1 probe. In this study, the
cDNA clones only encoding the intracellular domain of
Notch1 were screened, because this type of truncated Notch
protein is known to be constitutively active in Notch signal-
ing. Among the 20 clones selected, a clone named dl-3B was
found to have the longest cDNA insert, 3 kb. Therefore the
complete nucleotide sequence of the cDNA insert of this clone
was determined and its regions of interest are shown in Fig.
3A. Sequence analysis revealed that the 5P terminus of the
cDNA has good homology to the long terminal repeat
(LTR) sequences of a provirus of MuLV, a highly leukemo-
genic type C retrovirus[22], while the remainder of the cDNA
represents Notch1 sequences which encode the transmembrane
and intracellular domains of the Notch1 protein [2]. Further
detailed Southern analysis with Notch1- and MuLV-speci¢c
probes (data not shown) revealed that the full-length MuLV
provirus (9 kb) is inserted in the middle of an exon that
encodes amino acid sequences located between the Notch/
lin-12 repeats and the transmembrane domain of Notch1
(the provirus integration site corresponds to nucleotide posi-
Fig. 1. Southern blot hybridization demonstrating the rearrangement
of the Notch1 locus in DL-3. Genomic DNAs from the DL-3 and
normal DBA/2 spleen were digested with PstI (left panel) or BamHI
(right panel), Southern blotted, and hybridized with the Notch1 mid-
dle probe. Numbers on the right indicate the migration positions of
DNA molecular weight markers.
Fig. 2. The truncated Notch1 transcripts are highly expressed in
DL-3. Total RNAs from lymphoma cell lines with Notch1 rear-
rangement (DL-3) or not (333A and DL-5) were subjected to
Northern analyses with the Notch1 extracellular probe (left panel)
or the intracellular probe (middle panel). Approximate sizes of the
full-length transcript (8 kb) and the two truncated Notch1 tran-
scripts (5 kb and 3 kb in the left and the middle panels, respec-
tively) are indicated by arrowheads. For RNA loading controls, the
blot shown in the middle panel was stripped and reprobed with the
human elongation factor-1K (EF) probe (right panel).
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tion 4938 of the Notch1 cDNA, see Fig. 3B). Since the pro-
virus had integrated in the direction of Notch1 gene transcrip-
tion, the proviral 3P LTR appears to function as a promoter
for the 3-kb MuLV-Notch1 fusion transcript. On the other
hand, if the Notch1 transcription was to initiate from the
normal Notch1 promoter, it would terminate at the site of
provirus integration, and the expected size of the Notch1 tran-
script would be about 5 kb. In addition, the 5P LTR of the
integrated provirus probably provided strong enhancer(s) to
the Notch1 promoter to achieve high levels of Notch1 tran-
scription, and, at the same time, the sequence in the R region
of the same 5P LTR functioned as a termination signal for this
Notch1 transcript [24]. Thus this may be the reason why the
5-kb transcript encoding the extracellular domain of Notch1 is
markedly expressed in DL-3 (Fig. 2, left panel). This 5-kb
transcript may not a¡ect the expression of Notch1 target
genes, because it lacks a region encoding the intracellular
domain, which is essential for its signal transduction in the
cytoplasm and nucleus.
3.4. Ectopic expression of the truncated Notch1 protein in the
DL-3 cell line
Using the ATG codon at nucleotide position 5053 of the
Notch1 cDNA as an initiation methionine, the cDNA insert of
the dl-3B clone can encode a protein of about 100 kDa which
contains the transmembrane domain and the intracellular do-
main of Notch1 (Fig. 3A). Therefore expression of the Notch1
protein in DL-3, 333A, and DL-5 cell lines was analyzed by
Western blotting with antibody against the RAM23 domain
of Notch1 (Fig. 4A). Although none of these cell line express
the 300-kDa full-length Notch1 protein, the DL-3 cell line
expresses the 100-kDa truncated Notch1 protein which corre-
sponds to the expected size of the open reading frame in the
cDNA insert of dl-3B. Consistent with the nuclear transloca-
Fig. 3. Identi¢cation of a MuLV provirus insertion at the Notch1 locus in DL-3. A: The nucleotide sequence of the 5P terminus of the cDNA
insert of the dl-3B clone is shown. Numbers in italics and roman letters indicate the nucleotide positions of the MuLV LTR [22] and the wild-
type Notch1 cDNA sequences [2], respectively. The ATG codon for potential initiating methionine (indicated by a bold M) locates at nucleotide
position 5053 of the Notch1 cDNA sequence. The deduced amino acid sequence appears below the nucleotide sequence. R and U5 regions in
the MuLV LTR, and exon D and E regions of the Notch1 genome (see below) are indicated by right-angled arrows. B: Rearranged regions of
the Notch1 genome are shown together with a schematic representation of the full-length Notch1 cDNA. A restriction map of the rearranged
region of the Notch1 genome is shown. Exons and introns are indicated by open boxes and solid lines, respectively. Exons are labeled C, D, E
and F. Numbers indicate the nucleotide positions of the Notch1 cDNA. The insertion site of DL-3 is indicated by a vertical arrow. Restriction
sites: B, BamHI; Bg, BglII; K, KpnI; P, PstI; Pv, PvuII; Rv, EcoRV; S, SacI ; X, XbaI. The structural features of Notch1 cDNA are shown:
EGFR (EGF-like repeats), NLR (Notch/lin-12 repeats), TM (transmembrane domain), RAM (RAM23-homologous domain), ANK (Cdc10/
ankyrin repeats), PEST (PEST sequence motif). The extracellular, middle and intracellular probes used in Southern and Northern analyses are
shown with bars.
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tion model for Notch1 signaling, immunostaining with anti-
Cdc10/ankyrin repeat antibody (the anti-RAM23 antibody is
not good for immunostaining) revealed that the truncated
Notch1 localizes mainly in the nucleus in DL-3 cells (Fig.
4B, left panel).
3.5. Increase of HES-1 expression in the DL-3 cell line
The HES gene is known to be a target of Notch1 signaling.
Therefore levels of HES mRNA were compared between DL-
3 and DL-5 cell lines, with or without Notch1 gene rearrange-
ment, respectively. Northern blotting demonstrated that DL-3
expresses six-fold higher levels of HES-1 mRNA (1.7 kb) than
DL-5 (Fig. 5). On the other hand, we did not detect any
expression of HES-2, -3 and -5 in these cell lines (data not
shown). These results indicate that the truncated Notch1 pro-
tein expressed in the DL-3 cell line activates the Notch1 sig-
naling pathway and thus might contribute to the development
of this lymphoma in vivo.
4. Discussion
A number of studies in Drosophila and vertebrates have
indicated that loss of the extracellular domain of Notch rep-
resents a gain-of-function mutation which is implicated in
tumorigenesis. However, the molecular mechanisms by which
these constitutively active Notch proteins induce cell transfor-
mation are unknown. The HES-1 protein, a mammalian ho-
molog of the Drosophila hairy and enhancer of split, is known
to function in neurogenesis, retinal di¡erentiation and T cell
lineage decisions [12,13,19]. Recently, several in vitro experi-
ments have been reported demonstrating a link between
Notch1 signaling and the activation of HES-1 transcription;
expression of the intracellular region of Notch1 together with
RBP-J activates the transcription from the HES-1 promoter
carrying the RBP-J binding motif [3,8]. In HeLa cells express-
ing Notch1, a HES-1-derived promoter construct is transacti-
vated and levels of endogenous HES-1 mRNA are elevated in
response to Delta-1, a Notch1 ligand [10]. In addition, over-
expression of HES-1 leads to the silencer site-dependent re-
pression of the CD4 promoter as well as the downregulation
of endogenous CD4 expression in CD4CD8 helper T cells,
indicating a role for HES-1 in T cell di¡erentiation [25]. In
this view, the present study is the ¢rst to report a spontane-
ously developed mouse T cell lymphoma cell line demonstrat-
ing a correlation between activation of Notch1 signaling and
elevation of HES-1 mRNA. In the primary lymphoma sam-
ples from which the DL-3 cell line was established, we con-
¢rmed the same Notch1 rearrangement and expression of both
3- and 5-kb truncated Notch1 mRNA, as in DL-3, suggesting
the clonality of this lymphoma and the participation of over-
expressed HES-1 in this leukemogenesis. Beside HES-1 induc-
tion, the involvement of the nuclear factor (NF) UB family of
transcription factors in Notch1 signaling has been suggested;
Wang et al. [26] have reported that the truncated constitu-
tively active Notch1 has the functional properties of an IU-
B-like regulator with speci¢city for the NF-UB p50 subunit
and thus modulates the expression of NF-UB target genes in
T cells. Furthermore, RBP-J binding motifs were found to
overlap with UB elements (NF-UB binding motif) in promoters
of various NF-UB-inducible genes, indicating a novel role for
RBP-J in silencing NF-UB-inducible transcription [27]. Any-
way, the availability of a T cell line exhibiting a Notch1 gain-
of-function mutation may be instrumental in developing as-
says for Notch1 signaling in T cells. Finally, overexpression of
the truncated Notch1 in 32D myeloid progenitors inhibits
granulocytic di¡erentiation and permits expansion of undi¡er-
entiated cells [28], suggesting that an activated Notch1 has a
similar function in neoplastic cell proliferation and in other
hematopoietic systems.
Fig. 4. Expression and subcellular localization of the truncated
Notch1 protein in DL-3. A: Western analysis. Total cell lysates of
DL-3, 333A and DL-5 were analyzed by Western blotting with anti-
RAM23 antibody. The positions of the molecular weight markers
are indicated on the right. Intense 66-kDa bands present in all lanes
are non-speci¢c signals unrelated to Notch1. B: Immunostaining.
DL-3 cells stained with rabbit anti-Cdc10/ankyrin repeat serum and
control pre-immune serum are shown in the left and right panels,
respectively.
Fig. 5. Elevated expression of HES-1 mRNA in DL-3. Total RNA
isolated from DL-5, DL-3 cell lines was subjected to Northern blot
analysis with the HES-1 probe (left panel). The right panel is a blot
with the EF probe for RNA loading control.
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